Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.56 |
| ▸ | DRD2 | P14416 | 2/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | HTR7 | P34969 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6179069 | 0.92 | MEN1 (0.67) | MEN1KMT2ADRD2ATMMAPK1 | |
| SCHEMBL6181848 | 0.88 | MEN1 (0.55) | MEN1KMT2ADRD2ATMMAPK1 | |
| SCHEMBL6178229 | 0.83 | MEN1 (0.55) | MEN1KMT2ADRD2ATMMAPK1 | |
| SCHEMBL7536579 | 0.79 | HTR1A (0.56) | KMT2ADRD2MAPK1DRD4HTR7 | |
| Cyclohexane SCHEMBL6181887 | 0.79 | MEN1 (0.50) | MEN1KMT2ADRD2ATMMAPK1 | |
| SCHEMBL6068249 | 0.78 | DRD2 (0.55) | MEN1KMT2ADRD2ATMMAPK1 | |
| SCHEMBL13267602 | 0.77 | HRH3 (0.55) | — | |
| SCHEMBL6179800 | 0.77 | MEN1 (0.53) | MEN1KMT2ADRD2ATMDRD4 | |
| SCHEMBL8170155 | 0.74 | MEN1 (0.44) | MEN1KMT2ADRD2 | |
| SCHEMBL6007922 | 0.73 | SLC18A3 (0.57) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140830-B1 | ARYLPIPERIDINE AND ARYL-1,2,5,6-TETRAHYDROPYRIDINE AMIDE DERIVATIVES HAVING 5HT1A RECEPTOR ACTIVITY | WYETH CORP (US) | 2005-05-04 | — | — | EP | claimed |
| US-6503928-B2 | Central nervous system disorders; psychological disorders | WYETH | 2003-01-07 | — | — | US | disclosed |